Table 4.
Function | Group | 1 wk | 1 mo | 3 mo | 6 mo | 12 mo | 24 mo |
Prothrombin time (s)1 | Control | 16.2 ± 2.8 | 16.3 ± 2.8 | 15.9 ± 2.8 | 15.7 ± 2.9 | 15.5 ± 2.9 | 15.7 ± 2.3 |
BM-MNCs | 16.8 ± 2.5 | 15.5 ± 2.5 | 14.4 ± 2.3 | 13.9 ± 2.1 | 14.0 ± 2.1 | 14.4 ± 2.1 | |
P value | 0.472 | 0.311 | 0.046 | 0.019 | 0.051 | 0.06 | |
Prothrombin activity1 | Control | 72.5% ± 17.8% | 72.0% ± 17.7% | 74.4% ± 17.8% | 75.9% ± 18.2% | 77.4%± 18.2% | 75.6% ± 14.6% |
BM-MNCs | 68.7% ± 16.0% | 77.3% ± 15.7% | 84.3% ± 14.3% | 87.2% ± 13.3% | 86.9% ± 13.5% | 84.0% ± 13.6% | |
P value | 0.472 | 0.311 | 0.046 | 0.019 | 0.051 | 0.06 | |
Fibrinogen (g/L)1 | Control | 1.90 ± 0.58 | 1.92 ± 0.57 | 1.89 ± 0.44 | 1.97 ± 0.40 | 1.99 ± 0.39 | 1.93 ± 0.28 |
BM-MNCs | 1.86 ± 0.55 | 2.12 ± 0.64 | 2.28 ± 0.53 | 2.51 ± 0.55 | 2.49 ± 0.51 | 2.11 ± 0.52 | |
P value | 0.857 | 0.289 | 0.017 | 0.001 | 0.002 | 0.233 |
Data are expressed as the mean ± SD.
t test. BM-MNCs: Bone marrow mononuclear cells.